Determine if a strategy of monitoring for rejection that introduces AlloSure® into clinical practice does not lead to inferior renal allograft outcomes when compared to a strategy of monitoring for rejection that does not include AlloSure.
To evaluate post-transplant clinical outcomes in recipients of kidney transplants who are undergoing TruGraf and Trac monitoring.
Capture data in recipients of kidneys transplanted from donors with African ancestry.